Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

Seymour, John F.; Marcus, Robert; Davies, Andrew; Gallop-Evans, Eve; Grigg, Andrew; Haynes, Andrew; Herold, Michael; Illmer, Thomas; Nilsson-Ehle, Herman; Soekler, Martin; Duenzinger, Ulrich; Nielsen, Tina; Launonen, Aino; Hiddemann, Wolfgang

dc.contributor.author	Sökler, Martin
dc.date.accessioned	2021-02-03T12:24:55Z
dc.date.available	2021-02-03T12:24:55Z
dc.date.issued	2019
dc.identifier.issn	0390-6078
dc.identifier.uri	http://hdl.handle.net/10900/112367
dc.language.iso	en	de_DE
dc.publisher	Ferrata Storti Foundation	de_DE
dc.relation.uri	http://dx.doi.org/10.3324/haematol.2018.209015	de_DE
dc.subject.ddc	610	de_DE
dc.title	Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_01295
utue.publikation.seiten	1202-1208	de_DE
utue.personen.roh	Seymour, John F.
utue.personen.roh	Marcus, Robert
utue.personen.roh	Davies, Andrew
utue.personen.roh	Gallop-Evans, Eve
utue.personen.roh	Grigg, Andrew
utue.personen.roh	Haynes, Andrew
utue.personen.roh	Herold, Michael
utue.personen.roh	Illmer, Thomas
utue.personen.roh	Nilsson-Ehle, Herman
utue.personen.roh	Soekler, Martin
utue.personen.roh	Duenzinger, Ulrich
utue.personen.roh	Nielsen, Tina
utue.personen.roh	Launonen, Aino
utue.personen.roh	Hiddemann, Wolfgang
dcterms.isPartOf.ZSTitelID	Haematologica	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	104	de_DE